EP3984994
Setið píperídín-efnasamband sem orexín-örvi af gerð 2 til meðferðar við drómasýki
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.2.2017EP published:
3.7.2024EP application number:
21209107.8
EP translation filed:
30.9.2024Grant published:
15.11.2024EPO information:
European Patent Register
Max expiry date:
31.1.2037Expiry date:
31.1.2027Next due date:
28.2.2027
Title in English:
SUBSTITUTED PIPERIDINE COMPOUND AS OREXIN TYPE 2 AGONIST FOR THE TREATMENT OF NARCOLEPSYLanguage of the patent:
English
Timeline
Today
1.2.2017EP application
3.7.2024EP Publication
30.9.2024Translation submitted
15.11.2024Registration published
31.1.2027Expires
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP
Inventor
Name:
FUJIMOTO, TatsuhikoAddress:
Fujisawa-shi Kanagawa, 251-0012, JP
Name:
RIKIMARU, KentaroAddress:
Fujisawa-shi Kanagawa, 251-0012, JP
Name:
FUKUDA, KoichiroAddress:
Fujisawa-shi Kanagawa, 251-0012, JP
Name:
SUGIMOTO, HiromichiAddress:
Tokyo, 100-0005, JP
Name:
MATSUMOTO, TakahiroAddress:
Fujisawa-shi Kanagawa, 252-0804, JP
Name:
TOKUNAGA, NorihitoAddress:
Fujisawa-shi Kanagawa, 251-0012, JP
Name:
HIROZANE, MarikoAddress:
Fujisawa-shi Kanagawa, 251-0012, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
2016019834Date:
4.2.2016Country:
JP
Classification
Categories:
C07D 211/24, C07D 211/36, C07D 211/56, C07D 401/06, C07D 401/12, C07D 401/14, C07D 405/06, C07D 405/12, C07D 405/14, C07D 409/06, C07D 409/12, C07D 413/06, C07D 417/06, C07D 417/14, A61P 25/00, A61K 31/435
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 24.1.2025
Expires: 31.1.2026
Payer: Árnason Faktor ehf.
Number: 10
Paid: 4.2.2026
Expires: 31.1.2027
Payer: Árnason Faktor ehf.